A real-world observational study of belantamab mafodotin (belamaf) as a treatment for relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Cavo, M.; Delforge, M.; Dimopoulos, M.; Escalante, F.; Hultcrantz, M.; Kleinman, D.; Lee, H.; Vij, R.; Kotowsky, N.; Camadoo-O'Byrne, L.; Bitetti, J.; D'Estrube, T.; Fry, M.; Vossen, C. |
| Abstract Title: | A real-world observational study of belantamab mafodotin (belamaf) as a treatment for relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S166 |
| End Page: | S167 |
| Language: | English |
| ACCESSION: | WOS:001079705400290 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01856-6 |
| Notes: | Meeting Abstract: P-238 -- Source: Wos |
